Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 avr. 2026 08h00 HE | Source: Sonoro Gold Corp.

SONORO FILES UPDATED PRELIMINARY ECONOMIC ASSESSMENT FOR THE CERRO CALICHE PROJECT

VANCOUVER, Canada, April 15, 2026 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to report the filing of an Updated technical...
15 avr. 2026 08h00 HE | Source: Eco Innovation Group, Inc.

Eco Innovation Group, Inc. (ECOX) Initiates Frankfurt Exchange Dual Listing Process and Advances European SAF Strategy

Eco Innovation Group Initiates Frankfurt Exchange Dual Listing Process and Advances European SAF Strategy
15 avr. 2026 07h25 HE | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

MELBOURNE, Australia and SAN FRANCISCO, April 15, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
15 avr. 2026 07h00 HE | Source: Orvida Pharma Ltd

Orvida Pharma (formerly Kamari Pharma) Announces Favorable Phase 1a Safety Data for KM-023, a Potential First-in-Disease Oral TRPV3 Inhibitor, and Initiation of Phase 1b Study in Patients with Olmsted Syndrome

First Olmsted syndrome patient dosed in global Phase 1b study Company now operating under its new name, Orvida Pharma NESS ZIONA, Israel, April 15, 2026 (GLOBE NEWSWIRE) -- Orvida Pharma (formerly...
15 avr. 2026 07h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Announces Definitive Agreement to Acquire Robocath

ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today...
14 avr. 2026 21h00 HE | Source: Shanghai EpimAb Biotherapeutics Co., Ltd.

EpimAb Biotherapeutics to Present a Novel Prodrug T-Cell Engager (ProTCE) Platform at the 2026 American Association for Cancer Research Annual Meeting

SHANGHAI, April 15, 2026 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T-cell engagers, is pleased...
14 avr. 2026 19h04 HE | Source: Telix Pharmaceuticals Limited

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed with...
14 avr. 2026 17h40 HE | Source: Intermountain Health

Bruno Mars Presents $1 Million Gift to Intermountain Health for the Future Nevada Children’s Hospital

LAS VEGAS, April 14, 2026 (GLOBE NEWSWIRE) -- INTERMOUNTAIN NEWS RELEASE Link to Download Photos and B-Roll Video: https://lne.box.com/s/3xmd4yjhm8olepbj8d1amqsnkb7bh4s5 For Immediate...
14 avr. 2026 16h19 HE | Source: Corniche Capital

David Ebrahimzadeh Joins the New American Industrial Alliance as Corniche Capital Doubles Down on Reindustrialization, Defense Tech, and Build-to-Suit Industrial Real Estate

David Ebrahimzadeh of Corniche Capital joins NAIA, positioning the firm at the forefront of American reindustrialization, defense tech & BTM Industrial.
14 avr. 2026 16h00 HE | Source: Altus Group Limited

Altus Group unveils ARGUS Assist, the first AI-powered experience within the ARGUS Intelligence platform

TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, unveiled its latest agentic...

Page précédente

Page suivante